Capillariasis

disease
On this page

Also known as Capillaria infectioninfections, Capillaria

Summary

Capillariasis (MONDO:0001532) is a disease. A subtype of Enoplea infectious disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namecapillariasis
Mondo IDMONDO:0001532
DOIDDOID:12474
ICD-11839653996
SNOMED CT52979002
UMLSC0006897
MedGen507518
Is cancer (heuristic)no

Also known as: Capillaria infection · infections, Capillaria

Disease family

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious diseaseparasitic infectious diseasehelminthiasisNematoda infectious disease › Enoplea infectious disease › capillariasis

Related subtypes (3): dioctophymiasis, trichuriasis, trichinellosis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.